FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008540611> ?p ?o ?g. }

• W2008540611 endingPage "413" @default.
• W2008540611 startingPage "392" @default.
• W2008540611 abstract "The involvement of serine/threonine protein phosphatases in signaling pathways that control the expression of the cyclooxygenase-2 (COX-2) gene in human chondrocytes was examined. Okadaic acid (OKA), an inhibitor of protein phosphatases 1 (PP-1) and 2A (PP-2A), induced a delayed, time-dependent increase in the rate of COX-2 gene transcription (runoff assay) resulting in increased steady-state mRNA levels and enzyme synthesis. The latter response was dose dependent over a narrow range of 1–30 nmol/L with declining expression and synthesis of COX-2 at higher concentrations due to cell toxicity. The delayed increase in COX-2 mRNA expression was accompanied by the induction of the proto-oncogenes c-jun, junB, junD, and c-fos (but not FosB or Fra-1). Increased phosphorylation of CREB-1/ATF-1 transcription factors was observed beginning at 4 h and reached a zenith at 8 h. Gel-shift analysis confirmed the up-regulation of AP-1 and CRE nuclear binding proteins, though there was little or no OKA-induced nuclear protein binding to SP-1, AP-2, NF-κB or NF-IL-6 regulatory elements. OKA-induced nuclear protein binding to 32P-CRE oligonucleotides was abrogated by a pharmacological inhibitor of protein kinase A (PKA), KT-5720; the latter compound also inhibited OKA-induced COX-2 enzyme synthesis. Calphostin C (CalC), an inhibitor of PKC isoenzymes, had little effect in this regard. Inhibition of 32P-CRE binding was also observed in the presence of an antibody to CREB-binding protein (265-kDa CBP), an integrator and coactivator of cAMP-responsive genes. The binding to 32P-CRE was unaffected in the presence of excess radioinert AP-1 and COX-2 NF-IL-6 oligonucleotides, although a COX-2 CRE-oligo competed very efficiently. 32P-AP-1 consensus sequence binding was unaffected by incubation of chondrocytes with KT-5720 or CalC, but was dramatically diminished by excess radioinert AP-1 and CRE-COX-2 oligos. Supershift analysis in the presence of antibodies to c-Jun, c-Fos, JunD, and JunB suggested that AP-1 complexes were composed of c-Fos, JunB, and possibly c-Jun. OKA has no effect on total cellular PKC activity but caused a delayed time-dependent increase in total PKA activity and synthesis. OKA suppressed the activity of the MAP kinases, ERK1/2 in a time-dependent fashion, suggesting that the Raf-1/MEKK1/MEK1/ERK1,2 cascade was compromised by OKA treatment. By contrast, OKA caused a dramatic increase in SAPK/JNK expression and activity, indicative of an activation of MEKK1/JNKK/SAPK/JNK pathway. OKA stimulated a dose-dependent activation of CAT activity using transfected promoter-CAT constructs harboring the regulatory elements AP-1 (c-jun promoter) and CRE (CRE-tkCAT). We conclude that in primary phenotypically stable human chondrocytes, COX-2 gene expression may be controlled by critical phosphatases that interact with phosphorylation dependent (e.g., MAP kinases:AP-1, PKA:CREB/ATF) signaling pathways. AP-1 and CREB/ATF families of transcription factors may be important substrates for PP-1/PP-2A in human chondrocytes. J. Cell. Biochem. 69:392–413, 1998. © 1998 Wiley-Liss, Inc." @default.
• W2008540611 created "2016-06-24" @default.
• W2008540611 creator A5008845532 @default.
• W2008540611 creator A5015689271 @default.
• W2008540611 creator A5015709853 @default.
• W2008540611 creator A5021037922 @default.
• W2008540611 creator A5026711692 @default.
• W2008540611 creator A5053214598 @default.
• W2008540611 creator A5091607971 @default.
• W2008540611 date "1998-06-15" @default.
• W2008540611 modified "2023-10-17" @default.
• W2008540611 title "Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: Co-stimulation of AP-1 and CRE nuclear binding proteins" @default.
• W2008540611 cites W1484515711 @default.
• W2008540611 cites W1485442945 @default.
• W2008540611 cites W1488753908 @default.
• W2008540611 cites W1524131371 @default.
• W2008540611 cites W1964337986 @default.
• W2008540611 cites W1964504843 @default.
• W2008540611 cites W1972158551 @default.
• W2008540611 cites W1975624356 @default.
• W2008540611 cites W1976326847 @default.
• W2008540611 cites W1984274895 @default.
• W2008540611 cites W1990723702 @default.
• W2008540611 cites W1991161387 @default.
• W2008540611 cites W1991492172 @default.
• W2008540611 cites W1993876642 @default.
• W2008540611 cites W1996668125 @default.
• W2008540611 cites W1998956680 @default.
• W2008540611 cites W1999086913 @default.
• W2008540611 cites W2001615886 @default.
• W2008540611 cites W2002708977 @default.
• W2008540611 cites W2003599597 @default.
• W2008540611 cites W2005150284 @default.
• W2008540611 cites W2005386335 @default.
• W2008540611 cites W2012592975 @default.
• W2008540611 cites W2013687281 @default.
• W2008540611 cites W2022205459 @default.
• W2008540611 cites W2030807341 @default.
• W2008540611 cites W2040827725 @default.
• W2008540611 cites W2043382556 @default.
• W2008540611 cites W2043707891 @default.
• W2008540611 cites W2065477683 @default.
• W2008540611 cites W2068502127 @default.
• W2008540611 cites W2070386995 @default.
• W2008540611 cites W2081704409 @default.
• W2008540611 cites W2082728629 @default.
• W2008540611 cites W2082797919 @default.
• W2008540611 cites W2085680573 @default.
• W2008540611 cites W2094872845 @default.
• W2008540611 cites W2115350007 @default.
• W2008540611 cites W2115645802 @default.
• W2008540611 cites W2117935381 @default.
• W2008540611 cites W2118897660 @default.
• W2008540611 cites W2119361029 @default.
• W2008540611 cites W2132579331 @default.
• W2008540611 cites W2143241514 @default.
• W2008540611 cites W2148573797 @default.
• W2008540611 cites W2170618588 @default.
• W2008540611 cites W4247418433 @default.
• W2008540611 cites W4255402549 @default.
• W2008540611 doi "https://doi.org/10.1002/(sici)1097-4644(19980615)69:4<392::aid-jcb2>3.0.co;2-i" @default.
• W2008540611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9620167" @default.
• W2008540611 hasPublicationYear "1998" @default.
• W2008540611 type Work @default.
• W2008540611 sameAs 2008540611 @default.
• W2008540611 citedByCount "77" @default.
• W2008540611 countsByYear W20085406112012 @default.
• W2008540611 countsByYear W20085406112013 @default.
• W2008540611 countsByYear W20085406112014 @default.
• W2008540611 countsByYear W20085406112015 @default.
• W2008540611 countsByYear W20085406112017 @default.
• W2008540611 crossrefType "journal-article" @default.
• W2008540611 hasAuthorship W2008540611A5008845532 @default.
• W2008540611 hasAuthorship W2008540611A5015689271 @default.
• W2008540611 hasAuthorship W2008540611A5015709853 @default.
• W2008540611 hasAuthorship W2008540611A5021037922 @default.
• W2008540611 hasAuthorship W2008540611A5026711692 @default.
• W2008540611 hasAuthorship W2008540611A5053214598 @default.
• W2008540611 hasAuthorship W2008540611A5091607971 @default.
• W2008540611 hasConcept C104317684 @default.
• W2008540611 hasConcept C11960822 @default.
• W2008540611 hasConcept C150194340 @default.
• W2008540611 hasConcept C153911025 @default.
• W2008540611 hasConcept C1629964 @default.
• W2008540611 hasConcept C178666793 @default.
• W2008540611 hasConcept C184235292 @default.
• W2008540611 hasConcept C185592680 @default.
• W2008540611 hasConcept C195794163 @default.
• W2008540611 hasConcept C2776953658 @default.
• W2008540611 hasConcept C2779408958 @default.
• W2008540611 hasConcept C2781085546 @default.
• W2008540611 hasConcept C2909511254 @default.
• W2008540611 hasConcept C29512474 @default.
• W2008540611 hasConcept C55493867 @default.
• W2008540611 hasConcept C86339819 @default.
• W2008540611 hasConcept C86803240 @default.
• W2008540611 hasConcept C88045685 @default.
• W2008540611 hasConcept C97029542 @default.

• next